PNNL's Richard Smith Named To Prestigious Scientific American 50 List Of Outstanding Leaders
Main Category: Neurology / NeuroscienceArticle Date: 23 Dec 2007 - 4:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Richard D. Smith, Battelle Fellow at the U.S. Department of Energy's Pacific Northwest National Laboratory has been named one of 50 outstanding leaders in the 2007 Scientific American 50. Each year the magazine recognizes its list of 50 key contributors in science and technology. Smith shared the honor for creating a new approach to neurological diagnostics with a colleague from UCLA's David Geffen School of Medicine, Desmond Smith.
Smith's research may help identify the earliest detectable stages of Alzheimer's, Parkinson's and other neurological diseases. Smith's findings indicate that many neurodegenerative diseases leave a biochemical calling card, or biomarker, that may be used to predict early stages of brain impairment. The understandings from this research may result in the discovery of drug targets for new theraputic approaches. Many biomedical researchers also believe that detecting disease states before symptoms occur is key to reversing many as-yet-incurable diseases.
Smith's work led to the mapping of proteins in brain tissues. This mapping has allowed scientists to examine the location and abundance of large numbers of proteins within healthy brain tissue, which can be compared to protein portraits found within diseased brain tissues. These differences may help identify neurological diseases at a very early stage and proteins that might be targeted for drug intervention. It's hoped that such diseases might be curbed if caught and treated early enough.
Associate Laboratory Director for Fundamental & Computational Sciences, Doug Ray, said, "Dick Smith and his team have pushed the frontiers of proteomics instrumentation far beyond what we imagined just a few years ago. By integrating new ideas into the tools available to conduct research, they have made comprehensive proteomic mapping possible."
This research was supported by the National Institutes of Health and PNNL's Biomolecular Systems Initiative. Most of the work was conducted at the Department of Energy's W.R. Wiley Environmental Molecular Sciences Laboratory, a national scientific user facility located at PNNL.
The Board of Editors of Scientific American magazine selected Smith as one of 50 honorees chosen annually for accomplishments in research, business or policymaking, and demonstration of leadership in shaping both established and emerging technologies.
Past Scientific American 50 winners include stem cell researcher Douglas Melton, Nobel prize-winning neurobiologist Roderick MacKinnon, former World Health Organization Secretary General Gro Harlem Brundtland, Google founders Larry Page and Sergey Brin and Apple CEO Steve Jobs.
The complete list of this year's winners for the SA 50 appears in the January 2008 issue of Scientific American. It can also be viewed on the magazine's Web site, http://www.sciam.com/.
###
PNNL is a DOE Office of Science national laboratory that solves complex problems in energy, national security and the environment, and advances scientific frontiers in the chemical, biological, materials, environmental and computational sciences. PNNL employs 4,000 staff, has a $760 million annual budget, and has been managed by Ohio-based Battelle since the lab's inception in 1965.
EMSL is a DOE national scientific user facility located at PNNL that provides integrated experimental and computational resources for discovery and technological innovation in the environmental molecular sciences to support the needs of DOE and the nation.
Source:
Geoff Harvey
DOE/Pacific Northwest National Laboratory
Visit our neurology / neuroscience section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/92289.php>
APA
http://www.medicalnewstoday.com/releases/92289.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



